Kimberly Burgess, MD
Urology · Greenville, SCNPI 1578760450
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 93.1% of it on its own, with 11 other manufacturers making up the rest.
Across 77 payments — averaging $138.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Coloplast$376
- Boston Scientific$126
- Sumitomo Pharma America, Inc.$50
- Endo USA, Inc.$36
- Johnson & Johnson$31
- plus $123 from 6 others
Across 66 payments — averaging $3992.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$264K
What the payments were for
- Consulting fees$2,12520%
- Travel & lodging$6,05957%
- Food & beverage$2,50623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 50 | $9,947 |
| Coloplast | 13 | $376 |
| Boston Scientific | 2 | $126 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Endo USA, Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $31 |
| AbbVie | 1 | $26 |
| Accord Healthcare, Inc. | 1 | $25 |
| Tolmar, Inc. | 1 | $23 |
| 180 Medical, Inc. | 1 | $19 |
| Angiodynamics, Inc. | 1 | $16 |
| Urovant Sciences Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTAVIVA$1,659
- INTERSTIM$826
- ALTIS$152
- INTERSTIM ICON$144
- GENERAL PELVIC ORGAN PROLAPSE$111
How this compares
$10,690 in reported general payments places this provider in the 80th percentile of 196 urology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 316 | $193,309 |
| GemtesaVibegron | 214 | $157,519 |
| Mirabegron ErMirabegron | 35 | $17,448 |
| Estradiol | 93 | $4,762 |
| Solifenacin Succinate | 155 | $4,288 |
| Methenamine Hippurate | 38 | $2,664 |
| Oxybutynin Chloride ErOxybutynin Chloride | 74 | $1,766 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,075 |
| Oxybutynin Chloride | 17 | $789 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $500 |
| NitrofurantoinNitrofurantoin Macrocrystal | 17 | $461 |
| Cephalexin | 199 | $449 |
| Tamsulosin Hcl | 32 | $272 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 71 | $118 |
| Gentamicin Sulfate | 16 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $50 | $157,519214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 196 urology providers in South Carolina.
Other urology in Greenville
- Benjamin DropkinGreenville$65K
- Christopher BallantyneGreenville$37K
- Tim LargeGreenville$32K
- William SpringhartGreenville$20K
- Ryan WerntzGreenville$15K
- Neal ShoreMyrtle Beach$3.2M
- Manish PatelElgin$213K
- Sandip PrasadCharleston$177K
- Ian MarshallCharleston$60K
- Elizabeth BozemanFlorence$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.